Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
Managing Side Effects Based on Injection Timing Nausea is the most common early side effect of semaglutide, and timing can amplify or reduce its impact
If you're considering branded options, Ozempic and Zepbound are listed in Omzo's Terms at $1,299 and $1,399 per month respectively
If you notice irritation or inflammation around the injection site, dont worry
Boccal/sublingual administration provides comparable results to glutathione IV
It supports fat metabolism, but exercise increases energy demand and enhances fat utilisation